Net Savings Link EBITDA per Share
EBITDA per Share of Net Savings Link (NSAV) as of Aug 15, 2026.
Get this data via API
Financial Data API
EBITDA per Share
-0.00USD
Last updated:
EBITDA per Share of Net Savings Link is 2026 -0.00 USD. EBITDA per Share of Net Savings Link was 2025 - USD. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
Net Savings Link Stock analysis
What does Net Savings Link do? NSAV Holding Inc is a holding company based in New York. The company was founded in 2003 in the USA and originally focused on providing telecommunications services. Over time, the company has expanded its business and now offers various products and services in the technology, finance, and healthcare sectors.
NSAV's business model is to acquire, develop, and invest in technology, finance, and healthcare businesses. The company has several subsidiaries operating in these industries. The goal of NSAV is to build a diversified portfolio and increase corporate value through acquisitions and investments in different companies and technologies.
Technology is one of the key business areas for NSAV. The company has various subsidiaries that focus on software, hardware, and technology development. This includes the brand "Virus Applications," which provides a secure messaging platform. It is important to note that a secure messaging platform is a critical tool for exchanging confidential information and documents between individuals. The company also has a subsidiary called "Chromadrome," which specializes in video game development.
In addition to technology, NSAV also operates in the finance sector. The company's subsidiary "MagneGas Applied Technology Solutions" produces hydrogen gas that is particularly pure compared to the gas typically used for welding applications. This hydrogen gas offers many advantages and is more energy-rich than conventional gas. This makes it an environmentally friendly and efficient technology used in various industries, including healthcare. In addition to hydrogen gas production, MagneGas also provides solutions for the disposal of hazardous waste.
Healthcare is another important business area for NSAV. The company has a subsidiary called "Shanghai Tengwen Network and Technology Co., Ltd." that manufactures and distributes medical technology products. One of the key products of this subsidiary is a digital stethoscope that enables doctors to make quick and accurate diagnoses. The company also specializes in the development and distribution of medical instruments and regenerative therapies.
Another product line of the company is "InfinitiNET," which provides a Virtual Private Network (VPN). A VPN is a secure and private internet access, which is particularly important for companies that handle sensitive information.
In recent years, NSAV has become a strong player in the technology, finance, and healthcare sectors. The company aims to continue investing in these areas and expand its product range and customer base. However, it is worth noting that the company has a market capitalization of just over $100 million, which is why many investors are interested in its stocks, which may still have growth potential. Net Savings Link is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Net Savings Link stock
On Eulerpool you can find the complete historical development of EBITDA per Share Net Savings Link since 2006 – with annual values, charts, and detailed analysis.
EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.
Access this data via the Eulerpool API
Income Statement — Net Savings Link
All Key Metrics — Net Savings Link
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth